166 related articles for article (PubMed ID: 23279825)
21. Necrolytic Migratory Erythema Associated with a Glucagonoma.
Banerjee A; Shah SR
N Engl J Med; 2020 Aug; 383(6):e39. PubMed ID: 32757527
[No Abstract] [Full Text] [Related]
22. Glucagonoma syndrome with atypical necrolytic migratory erythema.
He S; Zeng W; Geng S; Jia J
Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
[TBL] [Abstract][Full Text] [Related]
23. Glucagonoma-Associated Necrolytic Migratory Erythema: The Broad Spectrum of the Clinical and Histopathological Findings and Clues to the Diagnosis.
Toberer F; Hartschuh W; Wiedemeyer K
Am J Dermatopathol; 2019 Mar; 41(3):e29-e32. PubMed ID: 30124507
[TBL] [Abstract][Full Text] [Related]
24. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
[TBL] [Abstract][Full Text] [Related]
25. Isolated cardiac metastasis in a patient with neuroendocrine carcinoma of pancreas discovered on ⁶⁸Ga-DOTANOC PET/CT.
Khangembam BC; Naswa N; Sharma P; Bal C; Malhotra A; Kumar R
J Nucl Cardiol; 2012 Oct; 19(5):1078-9. PubMed ID: 22538764
[TBL] [Abstract][Full Text] [Related]
26. Preoperative characterization of indeterminate large adrenal masses with dual tracer PET-CT using fluorine-18 fluorodeoxyglucose and gallium-68-DOTANOC: initial results.
Naswa N; Sharma P; Soundararajan R; Patnecha M; Lata S; Kumar R; Malhotra A; Bal C
Diagn Interv Radiol; 2013; 19(4):294-8. PubMed ID: 23439252
[TBL] [Abstract][Full Text] [Related]
27. Rare presentation of endocrine pancreatic tumor: a case of diffuse glucagonoma without metastasis and necrolytic migratory erythema.
Chen HW; Chen HW; Su DH; Shun CT; Liu KL
J Formos Med Assoc; 2005 May; 104(5):363-6. PubMed ID: 15959605
[TBL] [Abstract][Full Text] [Related]
28. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.
Kimbara S; Fujiwara Y; Toyoda M; Chayahara N; Imamura Y; Kiyota N; Mukohara T; Fukunaga A; Oka M; Nishigori C; Minami H
Clin J Gastroenterol; 2014 Jun; 7(3):255-9. PubMed ID: 26183746
[TBL] [Abstract][Full Text] [Related]
29. ⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.
Naswa N; Sharma P; Kumar A; Soundararajan R; Kumar R; Malhotra A; Ammini AC; Bal C
Clin Nucl Med; 2012 Mar; 37(3):245-51. PubMed ID: 22310250
[TBL] [Abstract][Full Text] [Related]
30. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
[TBL] [Abstract][Full Text] [Related]
31. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report.
Cao X; Wang X; Lu Y; Zhao B; Shi J; Guan Q; Zhang X
Medicine (Baltimore); 2019 Sep; 98(38):e17037. PubMed ID: 31567941
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
33. [Carcinoids and 68Ga-DOTANOC PET/CT].
Borghammer P; Arveschoug AK; Hjorthaug K; Kindt SE; Jakobsen KS
Ugeskr Laeger; 2013 Jan; 175(1-2):58. PubMed ID: 23305644
[No Abstract] [Full Text] [Related]
34. Necrolytic migratory erythema with recalcitrant dermatitis as the only presenting symptom.
Garner R; Ahern K; Poligone B
Cutis; 2016 Jun; 97(6):E6-7. PubMed ID: 27416097
[No Abstract] [Full Text] [Related]
35. Pancreatic glucagonoma with pancreatic calcification.
Gupta RA; Udwadia FE; Agrawal P; Doctor N
Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of somatostatin receptor PET/CT using 68Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings.
Naswa N; Sharma P; Soundararajan R; Karunanithi S; Nazar AH; Kumar R; Malhotra A; Bal C
Abdom Imaging; 2013 Jun; 38(3):552-60. PubMed ID: 22743840
[TBL] [Abstract][Full Text] [Related]
37. [CT findings in a case of glucagonoma with necrolytic migrating erythema].
Solivetti FM; Giunta S; Caterino M; De Majo A; Coscarella G; Carducci M
Radiol Med; 2001; 102(5-6):410-2. PubMed ID: 11779995
[No Abstract] [Full Text] [Related]
38. Necrolytic migratory erythema.
Kovács RK; Korom I; Dobozy A; Farkas G; Ormos J; Kemény L
J Cutan Pathol; 2006 Mar; 33(3):242-5. PubMed ID: 16466513
[TBL] [Abstract][Full Text] [Related]
39. Glucagonoma syndrome: a review and update on treatment.
John AM; Schwartz RA
J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2016-2022. PubMed ID: 27422767
[TBL] [Abstract][Full Text] [Related]
40. [Necrolytic migratory erythema in glucagonoma syndrome].
Stark I; Mensing CH; Sander CA
Hautarzt; 2008 Jan; 59(1):50-3. PubMed ID: 17549440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
